118 related articles for article (PubMed ID: 38489890)
1. Paeoniflorin promotes PPARγ expression to suppress HSCs activation by inhibiting EZH2-mediated histone H3K27 trimethylation.
Lan T; Li P; Zhang SJ; Liu SY; Zeng XX; Chai F; Tong YH; Mao ZJ; Wang SW
Phytomedicine; 2024 Jun; 128():155477. PubMed ID: 38489890
[TBL] [Abstract][Full Text] [Related]
2. EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ.
Du Z; Liu M; Wang Z; Lin Z; Feng Y; Tian D; Xia L
Cell Prolif; 2021 Jul; 54(7):e13072. PubMed ID: 34031939
[TBL] [Abstract][Full Text] [Related]
3. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H
Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480
[No Abstract] [Full Text] [Related]
4. EZH2-mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis.
Yang Y; Chen XX; Li WX; Wu XQ; Huang C; Xie J; Zhao YX; Meng XM; Li J
J Cell Mol Med; 2017 Oct; 21(10):2317-2328. PubMed ID: 28332284
[TBL] [Abstract][Full Text] [Related]
5. Carnosol-mediated Sirtuin 1 activation inhibits Enhancer of Zeste Homolog 2 to attenuate liver fibrosis.
Zhao H; Wang Z; Tang F; Zhao Y; Feng D; Li Y; Hu Y; Wang C; Zhou J; Tian X; Yao J
Pharmacol Res; 2018 Feb; 128():327-337. PubMed ID: 29106960
[TBL] [Abstract][Full Text] [Related]
6. Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis.
Martin-Mateos R; De Assuncao TM; Arab JP; Jalan-Sakrikar N; Yaqoob U; Greuter T; Verma VK; Mathison AJ; Cao S; Lomberk G; Mathurin P; Urrutia R; Huebert RC; Shah VH
Cell Mol Gastroenterol Hepatol; 2019; 7(1):197-209. PubMed ID: 30539787
[TBL] [Abstract][Full Text] [Related]
7. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis.
Mann J; Chu DC; Maxwell A; Oakley F; Zhu NL; Tsukamoto H; Mann DA
Gastroenterology; 2010 Feb; 138(2):705-14, 714.e1-4. PubMed ID: 19843474
[TBL] [Abstract][Full Text] [Related]
8. LncRNA H19-EZH2 interaction promotes liver fibrosis via reprogramming H3K27me3 profiles.
Li XJ; Zhou F; Li YJ; Xue XY; Qu JR; Fan GF; Liu J; Sun R; Wu JZ; Zheng Q; Liu RP
Acta Pharmacol Sin; 2023 Dec; 44(12):2479-2491. PubMed ID: 37580495
[TBL] [Abstract][Full Text] [Related]
9. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
10. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-34b-5p binds enhancer of zeste 2 to inhibit milk fat globule-EGF factor 8 expression, affecting liver fibrosis.
Ma J; Liu Q; Chen M; He B; Li Y; Zhang M; Jiang Y
J Physiol Biochem; 2022 Nov; 78(4):885-895. PubMed ID: 36138295
[TBL] [Abstract][Full Text] [Related]
12. Identification of Lineage-Specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution.
Liu X; Xu J; Rosenthal S; Zhang LJ; McCubbin R; Meshgin N; Shang L; Koyama Y; Ma HY; Sharma S; Heinz S; Glass CK; Benner C; Brenner DA; Kisseleva T
Gastroenterology; 2020 May; 158(6):1728-1744.e14. PubMed ID: 31982409
[TBL] [Abstract][Full Text] [Related]
13. Paeoniflorin modulates oxidative stress, inflammation and hepatic stellate cells activation to alleviate CCl4-induced hepatic fibrosis by upregulation of heme oxygenase-1 in mice.
Wang T; Zhou X; Kuang G; Jiang R; Guo X; Wu S; Wan J; Yin L
J Pharm Pharmacol; 2021 Mar; 73(3):338-346. PubMed ID: 33793876
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis.
Zhi SC; Chen SZ; Li YY; Li JJ; Zheng YH; Yu FX
Dig Dis Sci; 2019 Jun; 64(6):1560-1570. PubMed ID: 30673982
[TBL] [Abstract][Full Text] [Related]
15. PPARγ/NF-κB and TGF-β1/Smad pathway are involved in the anti-fibrotic effects of levo-tetrahydropalmatine on liver fibrosis.
Yu Q; Cheng P; Wu J; Guo C
J Cell Mol Med; 2021 Feb; 25(3):1645-1660. PubMed ID: 33438347
[TBL] [Abstract][Full Text] [Related]
16. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro.
Choi YJ; Kim DH; Kim SJ; Kim J; Jeong SI; Chung CH; Yu KY; Kim SY
Life Sci; 2014 Jul; 108(2):94-103. PubMed ID: 24880074
[TBL] [Abstract][Full Text] [Related]
17. n-3 PUFAs inhibit TGFβ1-induced profibrogenic gene expression by ameliorating the repression of PPARγ in hepatic stellate cells.
Hu S; Bae M; Park YK; Lee JY
J Nutr Biochem; 2020 Nov; 85():108452. PubMed ID: 32745880
[TBL] [Abstract][Full Text] [Related]
18. Histone H3K9 demethylase JMJD1A modulates hepatic stellate cells activation and liver fibrosis by epigenetically regulating peroxisome proliferator-activated receptor γ.
Jiang Y; Wang S; Zhao Y; Lin C; Zhong F; Jin L; He F; Wang H
FASEB J; 2015 May; 29(5):1830-41. PubMed ID: 25609425
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
[TBL] [Abstract][Full Text] [Related]
20. β-Catenin pathway is required for TGF-β1 inhibition of PPARγ expression in cultured hepatic stellate cells.
Qian J; Niu M; Zhai X; Zhou Q; Zhou Y
Pharmacol Res; 2012 Sep; 66(3):219-25. PubMed ID: 22706027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
